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Mutation pgsA affecting the phosphatidylglycerol ph sphate synthesis lethal for all but certain E. coil strains uch as strains deleted for the Ipp 
gone or strains containing unraodifiable prolipoprotein llke IppD14. Strain SD312 pgsA3 is tolerant to pgsA mutation, which suggests he Ipp alleles 
in strain SD312pgsA3 and its parental strain SDI2 may be defective. DNA sequence analynis ofthe lpp genes in Escherlchia coil strains SDI2 and 
SD312 pgsA using asymmetric polymerase chain reaction showed that the lpp alleles in these two strains contained a 63 base pair deletion 
corresponding to the 37th to 57th eodons of the wild-type Ipp gone. [~HlPalmitate lal~ling of strains $D12 and SDS312 showed that ~he mutant 
lipoprotein i  SDI 2 strain was modified with lipid, while the prollpoproteln i SD312 was not modified. The shortened mature iip~protein SDI2 
aud the lipid-modified prollpoprotein i  globomyein-treated SD12 were found to be covalently attached to the peptidoglycan, while the unmodified 
prolipoprotein i  SD312 did not form significant amounts of murein-bound lipoprot~in. 
lpp deletion mutant; Prolipoprotein modification and processing; Bound-form lipoprotein 
1. INTRODUCTION 
The E. coil murein iipoprotein is first synthesized as 
a precursor, the prolipoprotein, which contains a 
twenty amino acid residue signal peptide [1]. The pro- 
l ipoprotein undergoes a series of modification and proc- 
essing reactions to become the mature free-form lipo- 
protein, one third of  which is covalently attached to the 
peptidoglycan [2]. Lipid modification of the prolipopro- 
tein is a multi-step rocess; the first step is the transfer 
of  the glyceryl moiety from phosphatidylglycerol t  the 
cysteine residue in the unmodified prolipoprotein by 
prolipoprotein glyceryl transferzs~ [3]. O-aeylation of  
glyceryl-modified prolipoprotein by O-acyl trans- 
ferase(s) utilizes the major glyccrophosphatides 
(phosphatidylglycerol, phosphatidylethanolamine or 
cardiolipin) as the acyl donor  [4]. Asai and coworkers 
observed that the pgsA3 allele encoding a defective 
phosphatidylglycerophosphate synthase is lethal for all 
but certain £. coli strains such as SD strains [5]. pgsA3 
mutation is tolerated in the latter strains as well as in 
E, coli mutants deleted for the lpp gone and those con- 
taining unmodifiable mutant prolipoprotein such as 
IppDl4 [5]. These results suggest that the lipoprotein 
gene in SD strains may be defective as well. 
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In this paper, we report the cloning and DNA se- 
quence determination of the Ipp alleles in strains SDI2 
and SD312 pgsA3 using asymmetric polymerase chain 
reaction. Our results how that the lpp gone in these two 
strains contains a 63 base pair deletion corresponding 
to the 37th to 57th eodons of  the wild-type lpp gone. In 
spite of  this extensive alteration in the prolipoprotein 
structure, the mutant prol ipoprotein is modified, proc- 
essed and covalently attached to peptidoglycan i strain 
SDI2. 
2. MATERIALS  AND METHODS 
2.1. Bacterial strains and tnedium 
E. coil K-12 strain SDI2 (F-, Ipp-12gallgdSglpD3glpKglpR2his68 
phoA8 pyrD34 r~L118) and its acidic phospholipid-deficient deriva- 
tive, SD312 (SDI2 ds-I pgsA3) were gifts from 1. Shibuya [5]. Media 
used in this study included L broth, M9 glucose minimal medium 
supplemented with uracil (25/zg/ml), thiamine (5/zB/ml) and histldine 
(50/tghnl). 
2.2. Enzymes and ch,,micals 
Taq polymerase was from Perkin Elmer-Cotes Co. (Norwalk, CT). 
DNA sequenase kitwas from United States Biochemical Corp. (Cleve- 
land, OH). [~H]Palmitie acid (60 Ci/mmol) and [g-~SS]dATP (1200 
Ci/mmol) were from Amersham Corp. (Arlington Heights, IL). 
[~SS]Methionin¢ (I 000 Ci/mmol) was from ICN Biomedical Inc. (irvin, 
CA). Oligonu¢leotid¢ primers M! (GTGTAATACTTGTAACGC, 
Fig. 1 ) and M2 (GTAGCGGTAAACGGCAGAC0 Fig. l) were pur- 
chased from the Oligonueleotide Synthesis Facility, at the Uniformed 
Services University of the Health Sciences. Globomycin was obtained 
from M. Arai, Sankyo Co. (Tokyo, Japan). 
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Ml 
GGTTCTACTCPGCPGGCAGQTTGCTCCAGCAaCGCTAAAATCGATCAGCTGTCTTtTGACGTTCAGAC~~~~~~ 
CCaAGATGAGACGACCGTCCAACGAGGTCGTTGCGATT 
GlySeirhr~uLeulllaGlyCysSerSerASnAlaLysIlaAspGlnLeuSerSerAspValG1nThr~~nhl~yaVal~~l~u 
20 30 40 
AGC CGTl'CkGGC9GCTAAAGATGACGCAGCTCGTGCTAACCAGCGTCTGGACAACGGCTACTAAA 
T GWTGCAAGTCCGACGAT!lXCTACTGCGTCGAGCACGAT 
SerAs~~Ya~~e~~~~Val~l~l~laLysAepAspAlaAlaArgAlaAsnGlnArgLeuAspAsnMe~laThrLys 
50 60 70 
TACCGCAAGTAATAGTACCGTG~GTGTGGCGCACATTGTGCGACATTTTTTTTGTCn:CCGTTTACCGCTAC 
ATGGCGTTCATTATCATGGACA~TCACTTTTTACCGCGTGTAACACGCTGTA AAAAN&C.sGACGGCAAATGGCGATG 
TyrArgLysStop 
M2 
Pip. 1. PCR amplificalion and DNA sequence determination of the fpp alleles from strains SD312 and SDl2. The nucleotide and amino acid 
sequences ia bold-face are deleted in 1~@37-57 mutant strains SD12 and SD312 Ml and M2 are oligonuclrotidc primers used in PCR and DNA 
sequence analysis. 
2.3. PCR mrpliJlcrction of the Ipp ge/lu and seqnencc analysis of the 
PCR products 
Bacterial genomic DNA was isolated by the methods described by 
Silhavy et al. [6], PCR reactions were performed according to Erlich 
[7] in lOO@ reaction mixture containing 100 ng pnomic DNA, 10 mM 
Tris-HCI (pH 8.3), 50 mM KCI, I.5 mM MgCI,, 0.01% gelatin and 0.2 
mM each of dNTP. Taq polymerase (2.5 units) was added to the 
reaction mixture last. For asymmetric PCR, I pmol limiting primer 
(Ml) and 100 pmol excess primer (M2) were added to the reaction 
mixture, and the amplification was performed for 35 cycles with the 
addition of I unit Taq polymerase to the reaction mixture during the 
last 10 cycles. In each cycle, the reaction mixture was sequentially 
incubated at 94°C for I min. 55°C for 2 min and 72OC for I min. The 
products of asymmetric PCn were purified using microconcentrator 
Centricon 30 and used for sequencing. DNA sequencing was carried 
out using a sequencing kit and a protocol from the United States 
Biochemical Corp. The products of asymmetric; ?CR were treated 
with I N NaOH before annealing with the sequencing primer, which 
was the limiting primer (Ml) in the asymmetric PCR reaction. 
2.4. Lubali/lg atrd analysis of the free- und bawd-form lipoprotehs 
Strains SD12 and SD312 were labeled with [‘H]palmidc acid or 
[3’S]methionine; when indicated, globomycin (SOyg/ml) was added 20 
min prior to the labeling. Strains SD12 and SD312 were grown to 
Am,,,” = 0.3 in 5 ml M9 medium supplemented with glucose, required 
amino acids nnd growth factors, and labeled with 5OBCi [‘5S]methion- 
ine until AWlonm = 1.0. To study lipid modification of lipoprotein, 
strains SD12 and SD312 in 5 ml LB medium were labeled with 200 
&!i [‘Hlpalmitic acid for 1 h.The preparation or the cell envelope and 
the isolation of the free- and bound-form lipoproteins were performed 
as described 181, The radioactivities in the free- zx! bou!?dXoow lip+ 
protein were determined by liquid scintillation counting, and analyzed 
by Tricinc-SDS polyacrylamide gel electrophoresis u ing a l6.S% T 
and G% C separating el [9]. 
3. RESULTS 
3.1. PCR ur?splt&atiotz and sequence dererminarion of 
rhe 1pp alleles in strains SD12 am SD312 
The ipp alleles in strains SD1 2 and SD3 12 were am- 
plified by an asymmetric PCR, and the single-stranded 
PCR products were used directly in DNA sequencing. 
DNA sequence analysis using Ml oligonucleotide as the 
sequencing primer revealed that the ipp alleles in both 
strain SD12 and SD312 were identical, and contained 
a deletion of 63 base pair corresponding to the 37th to 
57th codons of the wild-type /pp gene of 6 cor’i (Fig. 1). 
In addition, used 
S’GGCTCTGCAGA%AATCTG03’tWOand I$?% 
CAGAGTAGAACCCAGGT, flanking the lpp pro- 
moter in asymmetric PCR followed by DNA sequenc- 
ing reactions. The DNA sequence from -320 bp to 14 
bp (based on the @p mRNA start site) in strains SD12 
and SD312 were found to be identical to that reported 
for the wild-type Ipp gene (data not shown). 
3.2. Lipid-modiJication and processing of tlteprolipopro- 
reins with a inlemal delerion in strains SD12 and 
SD312 
Ouchterlony test of the crude extract of strains SD12 
and SD312 revealed that strain SD 12 produced signifi- 
cant, albeit reduced, amounts of lipoprotein while 
SD312 contained negligible amounts of lipoprotein 
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(data not shown). [‘M]Palmitic acid labeling of strain 
SD12 showed that the shortened lipoprotein and prol- 
ipoprcteir. in control and globomycin-treated SD12 
cells were modified with lipid (Fig. 2, lanes 2 and 5). 
SDS-PAGE analysis of the [“%]methionine-labeled lipo- 
proteins from globomycin-treated SD1 2 cells revealed 
that the lipid-modified prolipoprotein SD12 was proc- 
essed by the signal peptidasc II (Fig. 3, lanes 2,s). Strain 
SD3 12 is defective in phosphatidylglycerol phosphate 
synthase; consequently, the prolipoprotein in SD312 
was not modified with lipid (Fig. 2, lane 6). Because of 
the lack in lipid modification, the unmodified prolipo- 
protein in mutant SD312 was not processed (Fig. 3, 
lanes 3, 6). 
3.3. Formation of murein-bound lipoprorein in lpp inter- 
real deleiiotz tnutatm 
SD12 and SD312 were checked for the phenotypes of 
leakiness of periplasmic RNase and sensitivity to so- 
dium dodecyl sulfate (SDS) as described previously 
[lO,ll]. Strain SD312 exhibited increased sensitivity to- 
ward SDS and leakiness of periplasmic RNase, while 
strain SD12 was SDS-resistant and RNase-nonleaky. 
These results suggest hat SD312 mutant might be de- 
fective in the attachment of murein-bound lipoprotein. 
The shortened free-form lipoprotein in strain SD 12 was 
covalently attached to the peptidoglycan (Table I and 
Fig. 3, lane 8). The lipid-modified prolipoprotein in 
globomycin-treated SD12 cells was also covalently at- 
tached to the peptidoglycan (Table I and Fig. 3, lane 
11). These results indicate that the deletion of internal 
twenty-one amino acid residues of prolipoprotein does 
PLP_ 
LP+- a 
@%a 
+pLP* 
1 2 345 6 
Fig. 2. SDS-polyacrylamide gel elcctrophoresis of [‘Hlpalmitic acid- 
labeled li’poprotcin and prhlipoprotein from the wild-type strain E6 I3 
and Ipp internal deletion mutant i;trains SD12 and SD312. Five ml 
cultures of these strains wcrc labeled with 200 @i [‘ki]pahnitic acid 
at A OW,,m = 0.3 for I h. Globamycin (SOyglml) was added’20 min prior 
to the labcling. Trichloroacetic acid (TCA) was addccl to a Rnal con- 
centration IO% to stop the labeling reaction. The TCA precipitation 
was collected by centrifugation at 5,000 x g for IO min at 4“C, washed 
with 3 ml cold acetone twice, dried in air and extracted with 100 ~1 
1% SDS (pH 7.0) at 100°C for 20 min, and the free-form lipoprotein 
was isolated from 1% SDS soluble fraction by a modifsed immunopre- 
cipitation procedure described previously [S]. Ten ~1 ofthe lipoprotein 
and prolipoprotein samples were loaded in each lane of a Tricinc-SDS 
gel. Lanes l-3 represent the kc-form lipoproteins kom E613, SD12 
and SC3i2, rospcctivcly, and !sn:s 4-5 tcprcsttZ the pro!ipoproteins 
from the &obompin-treated E613, SD12 and SD312, respectively. 
PLP, prolipoprotein; LP, lipoprotein; PLP, mutant prolipoprotcin; 
LP, mutant lipoprotein. 
1 2 3 4 5 6 7 8 9 IO 11 12 
Fig. 3. SDS-polyacrylamide 8~1 cktrophoresis of [??+]methionine- 
labeled free- and bound-form lipoprotcina from nnlins E6l.613, SD12 
and SD312 with or without dobomycin-treatment. The labeled cells 
were harvested, isrupted in a sonicator; the cell envelop was isolated 
by ccntrifuption at 200,000 xg, for I h at 4OC, and exlractcd with 
I% SDS at 100°C for 20 min. The free-form lipoprotein was isolated 
from the 1% SDS soluble fraction by immunoprecipitadon. The 1% 
SDS insoluble pellet was extracted with 4% SDS at IOWC for 30 min; 
and the murein sacculus containing bound-form lipoprotein was iso- 
lated by centrifuMtion at 200,000 x g for 90 min, washed with 6 ml 
water three times, resuspended in I50 ~1 IO mM sodium phosphate 
buffer and digested with 200 ydml lysozyme at 37OC overnight. Ten 
yl of the free- and bound-form lipoprotein were loaded in each lane 
of a Tricinr-SDS gel. (Lanes I-3) Free.rorm lipoprotein from strain 
EGI 3, SDI 2 and SD31 2, respectively; (lanes 4-G) prolipoproteins from 
globomycin-treated E613, SDI 2 and SD3 12, respectively; (lanes 7-9) 
bound form lipoprotein from E613, SD12 and SD312, rcspectivcly; 
(lanes IO-l?) m&n-bound prolipoprotcins from dobomycin-treated 
E613, SD12 and SD312. respectively. FF, mature free-form lipopro- 
tein; BF, wild-type bound-form (pro)lipoprotrin. 
not affect the formation of murein-bound lipoprotein. 
In contrast, the unmodified prolipoprotein in strain 
SD312 did not form murein-bound lipoprotein (Table 
I and Fig. 3, lane 9 and 12). This defect in the assembly 
of bound-form lipoprotein in SD312 probably results 
from a defective translocation of prolipoprolein in 
SD312 mutant cells. 
4. DISCUSSlON 
&ymmetric PCR has been successfully used for the 
amljlilicati& and DNA sequence analysis of the lpp 
alleles in strains SD12 and SD312. The lipoprotein in 
strains SD12 and SD31 2 was found to contain a dele- 
tion of twenty-one amino acid residues internal to lipo- 
protein. The deleted internal sequence of the prolipo- 
protein is not essential for the lipid modification and 
.processing of the prolipoprotein. This is consistent with 
: thaobservation that an Lpp-Bla hybrid prolipoprotein 
containing the Lpp signal sequence plus nine amino acid 
residues at the amino-terminal region of the mature 
lipoprotein followed by the /&lactamasc sequence is 
lipid-modified and processed like the wild-type lipopro- 
tein [12]. 
It is not surprising that the deletion of internal 
twenty-one amino acid residues does not affect the for- 
mation of murein-bound lipoprotein. Analysis of the 
amino aLiu JLyUbArc~ 0fi;ro.i,3,.~._... .‘-L “‘J....___ I’m mrn*~ins from E. co/i and 
four other enterobacteriaceae species including Prorelrs 
tnirabiiis, Morgatzella tnorganii, Erwinia utnylovora, and 
313 
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Table I 
Murein-bound lipoprotein contents in lpp internal d&ion, ?iutants 
Strain Murcin-bound lipoprotein 
(% of wild-type strain) 
EGl3 (wild-type) 100 
SD12 82 
SD312 8 
Globamycin-treated E613 47 
Globomycin-treated SD12 36 
Globomycin-trealed SD312 6 
Serruriu tnarccscens [13] reveals that the signal sequence 
of prolipoprotein, the amino-terminal sequence (CSl- 
L30) and the carboxy-terminal sequence (A62-K78) of 
the mature lipoprotein are highly conserved, with a se- 
quence homology of 65%, 70%, and 7 1 %, respectively. 
In contrast, the internal sequence of the prolipoprotein 
(S31-D61) has a low (32%) sequence homology. Our 
results indicate that the less conserved internal sequence 
of the prolipoprotein is not essential for the formation 
of murein-bound lipoprotein. 
The defect in the lipid-modification of the mutant 
prolipoprotein in strain SD3 12 pgsA3 is most likely due 
to the defective synthesis of phosphatidylglycerol phos- 
phate, which results in a deficiency of phosphatidylglyc- 
erol in the mutant cell envelope. However, the defect in 
the attachment of the unmodified prolipoprotein to the 
peptidoglycan i  strain SD312 is not due to the lack of 
lipid-modification and processing OF the mutant pro- 
lipoprotein. We have shown recently that neither the 
lipid-modification or the processing of prolipoprotein 
is a prerequisite for the formation of murein-bound 
lipoprotein [14]. Most likely, the defect in the formation 
of bound-form lipoprotein in mutant straip SD312 re- 
suits from a defective translocation of the prolipopro- 
tein across the cytoplasmic membrane. It has been re- 
ported that acidic phospholipids are required for the 
translocation of precursor proteins in E. colt’, both in 
vivo and in vitro [IS]. As a result of the defective 
translocation of prolipoprotein in strain SD312, the un- 
modified prolipoprotein is not attached to the pepti- 
doglycan in a reaction presumably occurring in the peri- 
plasm. 
The biochemical basis for the survival of strain 
SD3 12 containing the pgsA3 allele remains unknown. It 
is not clear how the internal deletion in the fpp gene 
might contribute to this tolerance to the pgsA3 allele, 
since the lppA37-57 deletion does not appear to affect 
the modification and processing of mutant prolipopro- 
tein in strain SD1 2. The tolerance of strain SD3 12 to the 
pgsA3 mutation may be related to the low level of 
(pro)lipoprotein in this mutant strain; Ouchterlony test 
revealed that SD312 strain contains greatly reduced 
amount of (pro)lipoprotein as compared to strain 
SDl2. The molecular basis for the reduced steady-state 
level of lipoprotein in this mutant remains to be deter- 
mined. 
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